Science ❯ Biology ❯ Immunology
T Cell Activation Chimeric Antigen Receptor T-cells T Cell Receptor Therapy Monoclonal Antibodies TIL Therapy Cytokines Nanoparticles Immune Checkpoint Inhibitors Vaccine Development Neoantigen Vaccines CAR-T Cell Therapy Gene Therapy
Researchers will use the findings to design a Phase II efficacy trial planned for late 2026.